skip to main content
Language:
Results 1 2 3 4 5 next page
Refined by: resource type: Conference Proceedings remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
P154/193  Impact of stent-retriever tip design on distal embolization during mechanical thrombectomy: a randomized in vitro evaluation
P154/193  Impact of stent-retriever tip design on distal embolization during mechanical thrombectomy: a randomized in vitro evaluation
Material Type:
Conference Proceeding 		Add to My Research

P154/193  Impact of stent-retriever tip design on distal embolization during mechanical thrombectomy: a randomized in vitro evaluation

Journal of neurointerventional surgery, 2023, Vol.15 (Suppl 2), p.A74-A74 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1759-8478 ;EISSN: 1759-8486 ;DOI: 10.1136/jnis-2023-ESMINT.182

Full text available

Citations Cited by
2
35752 Ultrasound vs fluoroscopy in the management of cervical radicular pain: can we replace fluoroscopy?
35752 Ultrasound vs fluoroscopy in the management of cervical radicular pain: can we replace fluoroscopy?
Material Type:
Conference Proceeding 		Add to My Research

35752 Ultrasound vs fluoroscopy in the management of cervical radicular pain: can we replace fluoroscopy?

Regional anesthesia and pain medicine, 2023, Vol.48 (Suppl 1), p.A211-A211 [Peer Reviewed Journal]

2023 American Society of Regional Anesthesia & Pain Medicine 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1098-7339 ;EISSN: 1532-8651 ;DOI: 10.1136/rapm-2023-ESRA.387

Full text available

Citations Cited by
3
731 Characterization of platinum resistance status by WGCNA co-expression modules in ovarian carcinoma patients
731 Characterization of platinum resistance status by WGCNA co-expression modules in ovarian carcinoma patients
Material Type:
Conference Proceeding 		Add to My Research

731 Characterization of platinum resistance status by WGCNA co-expression modules in ovarian carcinoma patients

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A304-A304 [Peer Reviewed Journal]

2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-ESGO.635

Full text available

Citations Cited by
4
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Material Type:
Conference Proceeding 		Add to My Research

111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A56-A56 [Peer Reviewed Journal]

2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.101

Full text available

Citations Cited by
5
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI
Material Type:
Conference Proceeding 		Add to My Research

052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.52 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.52

Full text available

Citations Cited by
6
490 National cancer research institute (NCRI) survey of hormone replacement therapyprescribing in gynaecological and breast cancer survivors and in women who have had risk-reducing oophorectomy in the United Kingdom
490 National cancer research institute (NCRI) survey of hormone replacement therapyprescribing in gynaecological and breast cancer survivors and in women who have had risk-reducing oophorectomy in the United Kingdom
Material Type:
Conference Proceeding 		Add to My Research

490 National cancer research institute (NCRI) survey of hormone replacement therapyprescribing in gynaecological and breast cancer survivors and in women who have had risk-reducing oophorectomy in the United Kingdom

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A357-A357 [Peer Reviewed Journal]

2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-ESGO.756

Full text available

Citations Cited by
7
OP98 Associations between adherence to cancer prevention recommendations and risk of cancer: a cohort study within the UK Biobank
OP98 Associations between adherence to cancer prevention recommendations and risk of cancer: a cohort study within the UK Biobank
Material Type:
Conference Proceeding 		Add to My Research

OP98 Associations between adherence to cancer prevention recommendations and risk of cancer: a cohort study within the UK Biobank

Journal of epidemiology and community health (1979), 2023, Vol.77 (Suppl 1), p.A48-A49 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0143-005X ;EISSN: 1470-2738 ;DOI: 10.1136/jech-2023-SSMabstracts.97

Full text available

Citations Cited by
8
O33 Qualitative story completion: an innovative method with exciting potential for health research
O33 Qualitative story completion: an innovative method with exciting potential for health research
Material Type:
Conference Proceeding 		Add to My Research

O33 Qualitative story completion: an innovative method with exciting potential for health research

BMJ open, 2019, Vol.9 (Suppl 1), p.A13-A13 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.33

Full text available

Citations Cited by
9
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies
Material Type:
Conference Proceeding 		Add to My Research

750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A783-A783 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0750

Full text available

Citations Cited by
10
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing
Material Type:
Conference Proceeding 		Add to My Research

1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1320-A1321 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1272

Full text available

Citations Cited by
11
364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study
364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study
Material Type:
Conference Proceeding 		Add to My Research

364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A70-A71 [Peer Reviewed Journal]

2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.124

Full text available

Citations Cited by
12
P17 Adopting the nominal group technique to understand the use of religious practices and experiences
P17 Adopting the nominal group technique to understand the use of religious practices and experiences
Material Type:
Conference Proceeding 		Add to My Research

P17 Adopting the nominal group technique to understand the use of religious practices and experiences

BMJ open, 2019, Vol.9 (Suppl 1), p.A20-A20 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.52

Full text available

Citations Cited by
13
769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
Material Type:
Conference Proceeding 		Add to My Research

769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A800-A800 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0769

Full text available

Citations Cited by
14
1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models
1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models
Material Type:
Conference Proceeding 		Add to My Research

1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1179-A1179 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1135

Full text available

Citations Cited by
15
526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
Material Type:
Conference Proceeding 		Add to My Research

526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A551-A551 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0526

Full text available

Citations Cited by
16
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
Material Type:
Conference Proceeding 		Add to My Research

1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1198-A1198 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1155

Full text available

Citations Cited by
17
715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials
715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials
Material Type:
Conference Proceeding 		Add to My Research

715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A748-A748 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0715

Full text available

Citations Cited by
18
021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE
021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE
Material Type:
Conference Proceeding 		Add to My Research

021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.21 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.21

Full text available

Citations Cited by
19
058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION
058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION
Material Type:
Conference Proceeding 		Add to My Research

058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.58 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.58

Full text available

Citations Cited by
20
Towards Computational Content Analysis of Crises-Related News in Electronic Media
Towards Computational Content Analysis of Crises-Related News in Electronic Media
Material Type:
Conference Proceeding 		Add to My Research

Towards Computational Content Analysis of Crises-Related News in Electronic Media

Central European Conference on Information and Intelligent Systems, 2023, p.407-416

2023. This work is published under http://archive.ceciis.foi.hr/app/index.php/ceciis/archive (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1847-2001 ;EISSN: 1848-2295

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Refine My Results

Creation Date 

From To
Refine
  1. Before 1985  (16)
  2. 1985 To 1998  (32)
  3. 1999 To 2006  (87)
  4. 2007 To 2015  (288)
  5. After 2015  (451)
  6. More options open sub menu

Language 

  1. English  (841)
  2. German  (12)
  3. French  (7)
  4. Hungarian  (4)
  5. Spanish  (3)
  6. Russian  (2)
  7. Polish  (1)
  8. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait